Supplementary Figure 2: Testing NetSig across 21 tumor types | Nature Methods

Supplementary Figure 2: Testing NetSig across 21 tumor types

From: NetSig: network-based discovery from cancer genomes

Supplementary Figure 2

In this figure, each box illustrates the results from the tumor-specific NetSig analyses of 17 tumor types that have at least four defined driver genes (first 17 boxes) or for pan-cancer genes (last box). In each plot (for example for breast cancer [BRCA, second box]), the AUC calculated with the NetSig score corresponding to mutation burdens from the tumor in question (NetSigBRCA) is indicated by the colored (in the case of BRCA, orange) line. The ability to distinguish BRCA driver genes using a NetSig score derived from pan-cancer data is indicated with a dark grey curve. The difference in performance using NetSigpan-cancer and NetSigBRCA (in this case 0.76-0.77 = - 0.01) is indicated above the plot as the differential AUC (or dAUC). In the case of BRCA the pan-cancer data is slightly better at classifying BRCA driver genes than the BRCA-specific mutation data.

Back to article page